ArticleJAAD case reports2025

Amivantamab, a bispecific epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with ulcerative intertrigo.

Hannah R Concannon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.